Q79.63 Vascular Ehlers-Danlos syndrome

Name of the Condition

• Vascular Ehlers-Danlos syndrome

Summary

Vascular Ehlers-Danlos syndrome (vEDS) is a rare inherited connective tissue disorder characterized by arterial, intestinal, or uterine fragility, leading to life-threatening complications such as rupture or dissection. It is distinguished by thin, translucent skin, easy bruising, and characteristic facial features. vEDS primarily affects blood vessels, the gastrointestinal tract, and the uterus, with symptoms often emerging in early adulthood. The condition results from genetic mutations that impair collagen synthesis, weakening vascular and organ walls.

Causes

vEDS is caused by mutations in the COL3A1 gene, which encodes type III collagen, a key component of blood vessel walls and other tissues. These mutations disrupt collagen structure, leading to weakened connective tissues. The condition follows an autosomal dominant inheritance pattern, meaning a single mutated copy of the gene from a parent can cause the disorder. Most cases are familial, though spontaneous mutations may occur.

Risk Factors

• Family history of vascular Ehlers-Danlos syndrome or related connective tissue disorders.
• Inherited COL3A1 gene mutations.
• Advanced maternal age (in rare spontaneous cases).

Symptoms

• Arterial rupture, dissection, or aneurysm, often without trauma.
• Spontaneous organ rupture (e.g., intestine, uterus).
• Thin, translucent skin with visible veins.
• Easy bruising or bleeding.
• Characteristic facial features (e.g., thin nose, lips, or ears).
• Joint hypermobility or mild skin hyperextensibility.

Diagnosis

Diagnosis involves clinical evaluation, family history, and genetic testing for COL3A1 mutations. Imaging (e.g., MRI, CT angiography) may detect vascular abnormalities. Skin biopsy or collagen analysis can support diagnosis but is less specific. Criteria include arterial rupture, organ rupture, or a first-degree relative with vEDS, plus genetic confirmation or typical clinical findings.

Treatment Options

Management focuses on preventing complications and monitoring vascular health. Regular imaging of major arteries is recommended. Beta-blockers or other medications may reduce arterial stress. Surgical repair of vascular or organ ruptures is necessary but carries high risk. Genetic counseling is advised for affected individuals and families.

Prognosis and Follow-Up

Prognosis is guarded due to the risk of sudden, life-threatening complications. Lifespan may be reduced, with arterial events being the leading cause of mortality. Regular follow-up with vascular specialists and geneticists is essential. Monitoring for early signs of rupture (e.g., sudden pain) is critical for timely intervention.

Complications

• Sudden arterial rupture or dissection.
• Spontaneous organ perforation (e.g., intestine, uterus).
• Chronic pain or disability from prior complications.
• Psychological distress due to disease severity.

Lifestyle & Prevention

Avoid contact sports or high-impact activities to reduce injury risk. Manage blood pressure to minimize vascular stress. Promptly address any unexplained pain or bleeding. Genetic counseling helps families understand inheritance and reproductive risks.

When to Seek Professional Help

Seek immediate care for sudden, severe pain (e.g., chest, abdomen, or limb), unexplained bruising, or signs of organ rupture (e.g., vomiting blood, severe abdominal pain). Regular check-ups are vital for monitoring vascular health.

Tips for Medical Coders

Document clinical findings supporting vEDS, such as arterial/organ rupture, skin changes, or genetic testing results. Ensure the COL3A1 mutation or clinical criteria are clearly recorded. Use this code only when vEDS is confirmed; avoid it for unspecified or other EDS subtypes.